Freespira
-
Advocates of Digital Therapies Hope Bill Can Ease Reimbursement
A similar bill appeared last year but did not progress. Given the potential costs of reimbursing prescription digital therapeutics, Congress could be skeptical. Still, with growing attention on mental health, advocates are optimistic.
-
CEO of digital therapeutics business Freespira talks about its approach to anxiety disorders
Freespira CEO Dean Sawyer said its FDA cleared digital therapeutic is the first that’s proven to significantly reduce or eliminate symptoms of panic attacks, panic disorder, and PTSD, in a single, 28-day treatment episode.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Highmark expands access to device that helps manage panic, PTSD symptoms
The payer is expanding access to telehealth coaching for Freespria’s digital device, which aims to eliminate or reduce symptoms of panic disorders and post-traumatic stress disorder.
-
Hospitals, Startups, Health Tech, Payers
Can Highmark successfully commercialize the healthcare innovation process?
Highmark Health is turning its internal VITAL Innovation program into a commercial offering meant to help startups test their products in real-world clinical environments.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
